OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020

Background Heart failure (HF) is an increasing health problem globally. Profound sex-related differences have been observed regarding the cause, treatment, and prognosis of HF.Aim To assess baseline predictors for achieving optimal medical treatment (OMT) and the prognostic importance of OMT for mal...

Full description

Saved in:
Bibliographic Details
Main Authors: Alaa Sharfo, Astrid Lahn Sørensen, Emil Eik Nielsen, Ilan Esra Raymond, Anne Merete Boas Soja, Michael Hecht Olsen
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Blood Pressure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/08037051.2025.2481229
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849766492153839616
author Alaa Sharfo
Astrid Lahn Sørensen
Emil Eik Nielsen
Ilan Esra Raymond
Anne Merete Boas Soja
Michael Hecht Olsen
author_facet Alaa Sharfo
Astrid Lahn Sørensen
Emil Eik Nielsen
Ilan Esra Raymond
Anne Merete Boas Soja
Michael Hecht Olsen
author_sort Alaa Sharfo
collection DOAJ
description Background Heart failure (HF) is an increasing health problem globally. Profound sex-related differences have been observed regarding the cause, treatment, and prognosis of HF.Aim To assess baseline predictors for achieving optimal medical treatment (OMT) and the prognostic importance of OMT for male and female patients who have attended a HF clinical program (HFCP).Methods OPTIHEART was a retrospective study that included 870 consecutive patients with left ventricular ejection fraction (LVEF)≤40% discharged from HFCP in 2018, 2019 or 2020 and followed in registers for a mean of 1083(SD 11.3) days. OMT was defined as receiving an angiotensin-converting-enzyme-inhibitor (ACEi), angiotensin-receptor blocker (ARB) or angiotensin-II-receptor blocker and nephrylisin-inhibitor (ARNI) AND a betablocker (BB) both in doses ≥ 50% of target doses.Results Achieving OMT was associated with male sex (OR: 2.05 95%CI 1.44-2.97; p < 0.0001) independently of younger age, higher diastolic blood pressure (DBP), and lower creatinine. A lower rate of 5-point MACE was associated with achieved OMT (HR: 0.67 95%CI 0.50-0.90; p = 0.007) independently of female sex (HR: 0.64 95%CI 0.48-0.84; p = 0.002), younger age, never smoking and NYHA ≤ 2. The beneficial effect of OMT was insignificantly more pronounced in patients with male sex, older age, higher creatinine, lower DBP, and body mass index ≤25kg/m2.Conclusion OMT was more frequently achieved in patients with male sex independently of age, DBP, and creatinine. Achieving OMT was associated with less 5-point MACE independently of female sex, younger age, never smoking and NYHA ≤ 2.
format Article
id doaj-art-d8db0208d9114841b47dfa0f9e561559
institution DOAJ
issn 0803-7051
1651-1999
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Blood Pressure
spelling doaj-art-d8db0208d9114841b47dfa0f9e5615592025-08-20T03:04:34ZengTaylor & Francis GroupBlood Pressure0803-70511651-19992025-12-0134110.1080/08037051.2025.2481229OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020Alaa Sharfo0Astrid Lahn Sørensen1Emil Eik Nielsen2Ilan Esra Raymond3Anne Merete Boas Soja4Michael Hecht Olsen5Department of Internal Medicine 1, Holbaek Hospital, Holbaek, DenmarkDepartment of Internal Medicine 1, Holbaek Hospital, Holbaek, DenmarkDepartment of Internal Medicine 1, Holbaek Hospital, Holbaek, DenmarkDepartment of Cardiology, Copenhagen University Hospital, Amager and Hvidovre Hospital, Hvidovre, DenmarkDepartment of Internal Medicine 1, Holbaek Hospital, Holbaek, DenmarkDepartment of Internal Medicine 1, Holbaek Hospital, Holbaek, DenmarkBackground Heart failure (HF) is an increasing health problem globally. Profound sex-related differences have been observed regarding the cause, treatment, and prognosis of HF.Aim To assess baseline predictors for achieving optimal medical treatment (OMT) and the prognostic importance of OMT for male and female patients who have attended a HF clinical program (HFCP).Methods OPTIHEART was a retrospective study that included 870 consecutive patients with left ventricular ejection fraction (LVEF)≤40% discharged from HFCP in 2018, 2019 or 2020 and followed in registers for a mean of 1083(SD 11.3) days. OMT was defined as receiving an angiotensin-converting-enzyme-inhibitor (ACEi), angiotensin-receptor blocker (ARB) or angiotensin-II-receptor blocker and nephrylisin-inhibitor (ARNI) AND a betablocker (BB) both in doses ≥ 50% of target doses.Results Achieving OMT was associated with male sex (OR: 2.05 95%CI 1.44-2.97; p < 0.0001) independently of younger age, higher diastolic blood pressure (DBP), and lower creatinine. A lower rate of 5-point MACE was associated with achieved OMT (HR: 0.67 95%CI 0.50-0.90; p = 0.007) independently of female sex (HR: 0.64 95%CI 0.48-0.84; p = 0.002), younger age, never smoking and NYHA ≤ 2. The beneficial effect of OMT was insignificantly more pronounced in patients with male sex, older age, higher creatinine, lower DBP, and body mass index ≤25kg/m2.Conclusion OMT was more frequently achieved in patients with male sex independently of age, DBP, and creatinine. Achieving OMT was associated with less 5-point MACE independently of female sex, younger age, never smoking and NYHA ≤ 2.https://www.tandfonline.com/doi/10.1080/08037051.2025.2481229Heart failuresex-related differencesoptimal medical treatmentprognosisrehabilitation
spellingShingle Alaa Sharfo
Astrid Lahn Sørensen
Emil Eik Nielsen
Ilan Esra Raymond
Anne Merete Boas Soja
Michael Hecht Olsen
OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020
Blood Pressure
Heart failure
sex-related differences
optimal medical treatment
prognosis
rehabilitation
title OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020
title_full OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020
title_fullStr OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020
title_full_unstemmed OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020
title_short OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020
title_sort optiheart determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020
topic Heart failure
sex-related differences
optimal medical treatment
prognosis
rehabilitation
url https://www.tandfonline.com/doi/10.1080/08037051.2025.2481229
work_keys_str_mv AT alaasharfo optiheartdeterminantsandprognosticimportanceofoptimalmedicaltreatmentinpatientswithheartfailurewithreducedejectionfractiondischargedfromaheartfailureclinicfrom2018to2020
AT astridlahnsørensen optiheartdeterminantsandprognosticimportanceofoptimalmedicaltreatmentinpatientswithheartfailurewithreducedejectionfractiondischargedfromaheartfailureclinicfrom2018to2020
AT emileiknielsen optiheartdeterminantsandprognosticimportanceofoptimalmedicaltreatmentinpatientswithheartfailurewithreducedejectionfractiondischargedfromaheartfailureclinicfrom2018to2020
AT ilanesraraymond optiheartdeterminantsandprognosticimportanceofoptimalmedicaltreatmentinpatientswithheartfailurewithreducedejectionfractiondischargedfromaheartfailureclinicfrom2018to2020
AT annemereteboassoja optiheartdeterminantsandprognosticimportanceofoptimalmedicaltreatmentinpatientswithheartfailurewithreducedejectionfractiondischargedfromaheartfailureclinicfrom2018to2020
AT michaelhechtolsen optiheartdeterminantsandprognosticimportanceofoptimalmedicaltreatmentinpatientswithheartfailurewithreducedejectionfractiondischargedfromaheartfailureclinicfrom2018to2020